First drug to slow Alzheimer’s progression gets approved in the US and decision for the UK is ‘on the horizon’
7 July 2023
"This decision badges Alzheimer's disease as an illness which can potentially be treated or prevented, rather than simply endured," said Professor David Curtis (UCL Biosciences) on the Alzheimer's drug lecanemab which may soon be approved in the UK.
Close
